Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Retia Medical Raises $15M Series B

2022-07-18
VALHALLA, NY, Retia Medical, an innovator in advanced hemodynamic monitoring, has secured $15 million in Series B funding.
Retia Medical, an innovator in advanced hemodynamic monitoring, has secured $15 million in Series B funding. The financing round was led by Fresenius Medical Care Ventures with participation from a second strategic investor, Red Cedar Ventures, and existing investor, the Pritzker-Vlock Family Office.

Retia Medical aims to provide accurate cardiovascular information and insights to help clinicians improve outcomes for high-risk patients. Retia brings together industry-leading expertise in physiology, signal processing, data science, and computational algorithms to engineer innovative hemodynamic monitoring solutions that give clinicians accurate, real-time data that they can rely on to make patient care decisions.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors